Filozof C, Fernández Pinilla M C, Fernández-Cruz A
Unidad de Tabaquismo, Area de Prevención y Rehabilitación Cardíaca, Instituto Cardiovascular, Hospital Clínico San Carlos, Universidad Complutense, Madrid, Spain.
Obes Rev. 2004 May;5(2):95-103. doi: 10.1111/j.1467-789X.2004.00131.x.
Cigarette smoking is the single most important preventable cause of death and illness. Smoking cessation is associated with substantial health benefits. Weight gain is cited as a primary reason for not trying to quit smoking. There is a great variability in the amount of weight gain but younger ages, lower socio-economic status and heavier smoking are predictors of higher weight gain. Weight change after smoking cessation appears to be influenced by underlying genetic factors. Besides, weight gain after smoking cessation is largely because of increased body fat and some studies suggest that it mostly occurs in the subcutaneous region of the body. The mechanism of weight gain includes increased energy intake, decreased resting metabolic rate, decreased physical activity and increased lipoprotein lipase activity. Although there is convincing evidence for the association between smoking cessation and weight gain, the molecular mechanisms underlying this relationship are not well understood. This review summarizes current information of the effects of nicotine on peptides involved in feeding behaviour. Smoking was shown to impair glucose tolerance and insulin sensitivity and cross-sectional studies have demonstrated that smokers are insulin-resistant and hyperinsulinaemic, as compared with non-smokers. Smoking cessation seems to improve insulin sensitivity in spite of the weight gain. Nicotine replacement - in particular nicotine gum - appears to be effective in delaying post-cessation weight gain. In a group of women who failed to quit smoking because of weight gain, a dietary intervention (intermittent very-low-calorie diet) plus nicotine gum showed to both increase success rate in terms of smoking cessation and prevent weight gain. On the other hand, body weight gain at the end of treatment was significantly lower in the patients receiving bupropion or bupropion plus nicotine patch, compared with placebo. Studies with new drugs available for the treatment of obesity - sibutramine and orlistat - are warranted.
吸烟是导致死亡和疾病的唯一最重要的可预防因素。戒烟对健康有诸多益处。体重增加被认为是不愿尝试戒烟的主要原因。体重增加的幅度差异很大,但年龄较小、社会经济地位较低和吸烟量较大是体重增加较多的预测因素。戒烟后的体重变化似乎受潜在遗传因素影响。此外,戒烟后体重增加主要是由于体脂增加,一些研究表明,这主要发生在身体的皮下区域。体重增加的机制包括能量摄入增加、静息代谢率降低、身体活动减少和脂蛋白脂肪酶活性增加。尽管有确凿证据表明戒烟与体重增加之间存在关联,但这种关系背后的分子机制尚不清楚。本综述总结了尼古丁对参与进食行为的肽类影响的现有信息。研究表明,吸烟会损害葡萄糖耐量和胰岛素敏感性,横断面研究表明,与不吸烟者相比,吸烟者存在胰岛素抵抗和高胰岛素血症。尽管体重增加,但戒烟似乎能改善胰岛素敏感性。尼古丁替代疗法——尤其是尼古丁口香糖——似乎能有效延缓戒烟后的体重增加。在一组因体重增加而未能戒烟的女性中,饮食干预(间歇性极低热量饮食)加尼古丁口香糖既能提高戒烟成功率,又能防止体重增加。另一方面,与安慰剂相比,接受安非他酮或安非他酮加尼古丁贴片治疗的患者在治疗结束时体重增加明显较低。有必要对可用于治疗肥胖症的新药——西布曲明和奥利司他——进行研究。